Latest filing: Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday, 14Th July, 2026.
ObservedCompany dossier
Welcure Drugs & Pharmaceuticals
BSE:WELCURE · ISIN INE331C01025
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Welcure Drugs & Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group N/A and public 100.00% as of 31 Mar 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday, 14Th July, 2026.
BSE · exchange filing
Observed
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
BSE · exchange filing
Observed
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday, 19Th June, 2026
BSE · exchange filing
Observed
Source filing Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →31 Mar 2026
- Promoter group
- N/A
- Public
- 100.00%
- Employee trust
- N/A
Observed BSE shareholding XBRL